SCHEDULE 13G

Neurogene Inc

Common Stock · CUSIP: 64135M105

Event date: 2025-12-08

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Trails Edge Capital Partners, LP

  Shares: 785,000.00 · Class: 5.1%

• Trails Edge Biotechnology Master Fund, LP

  Shares: 785,000.00 · Class: 5.1%

• Ortav Yehudai

  Shares: 785,000.00 · Class: 5.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.